Intelligencia AI
Predict drug success with AI, but relies on comprehensive data inputs.
At a glance
Starts at
Free
No paid plan found on the vendor's site, September 2026.
Free tier
Yes
Platforms
Web, macOS, Windows
Best for
Pharma companies looking to de-risk clinical development.
Not for
Teams needing datasets for niche therapeutic areas
4.0 out of 5
Scored by a Toolio reviewer after real useOur verdict
Intelligencia AI helps make informed decisions in drug development. But it requires high-quality, detailed input data for accurate predictions.
✓What it does well
Predictive accuracyHigh prospective accuracy (>80%) vs. retrospective-only analyses of AI models.
Real-time trackingContinuous real-time monitoring and validation of clinical programs.
Expert curationData quality controlled by biomedical professionals.
✕Where it falls short
Data dependencyRequires comprehensive, precise data for accurate predictions.
Complex input requirementsHigh-quality and detailed data inputs are necessary but can be expensive.
Limited public datasetsMay not provide access to custom-built, in-house datasets for all therapeutic areas.
Key features
Portfolio OptimizerBolster internal risk identification with accurate AI-driven assessments.
Dynamic BenchmarksStandardize risk evaluation processes across entire portfolios.
Explainable AITransparency into PTRS predictions with hundreds of dimensions.
Conference IntelligenceSurfaces insights gathered from industry conferences and publications.